CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- 4 Grant or award Chief Scientific Officer acquired 22,507 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 22,714 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 55,117 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 19,422 shares (grant or award)
- 4 Grant or award President and COO acquired 25,507 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 21,298 shares (grant or award)
- 4 Grant or award See Remarks acquired 12,378 shares (grant or award)
- 4 Grant or award See Remarks acquired 18,422 shares (grant or award)
- S-4 POS Other S-4 POS
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 4 of 34 · 678 filings